Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.26

+0.01 (+4.08%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +14,796.2% upside

Low Target $26.34

Average Target $38.73

High Target $46.19

Current Price $0.26

Current
$0.26

Target
$38.73

$26.34 $38.73 avg $46.19

Scenario Analysis

Bear Case

$26.34

10,030.8%

Low target

Base Case

$38.73

+14,796.2%

Avg target

Bull Case

$46.19

+17,665.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$0.86

-69.9% from high

52-Week Low

$0.16

+59.7% from low

Target vs 52W High

$38.73

+4,386.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-38.5%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%